Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

43 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-31

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intents to determine who will benefit from an intensive brief stress coping intervention week (ISCIW) as secondary prevention for real world affective disorder patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of an ICU Diary on the Well-being of Patients and Families. A Prospective Multicenter Mixed Study

NCT02519725

Stress Disorders Post Traumatic

COMPLETED NA

Chronobiological and ACT-based Training to Handle Stress at Work

NCT04290117

Stress

UNKNOWN NA

Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors

NCT06538246

Depression Anxiety Post-traumatic Stress Disorder +3 more

RECRUITING NA

Relaxation Effects of Personalized Breathing Exercises for Healthy College Students

NCT06121596

Breathing Exercises

COMPLETED NA

Stress in Medical Staff and Controls

NCT03929627

Stress

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Affective disorders are associated with a substantial personal and socio-economic burden. This study evaluates an intensive brief stress-coping intervention week (ISCIW) as feasible follow-up treatment for real world patients who suffer from this highly prevalent and chronic stress-related disorders. Stress-associated blood (Interleukin-6, Homocystein, Myeloperoxidase), saliva cortisol and psychosocial screening parameters will be analyzed to determine who will benefit from the ISCIW. All patients were identified in a preventive medical screening before pre-treatment for at least three month as outpatient and the following inclusion to the follow-up ISCIW-trial at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria. For the three planed groups and interventions see interventions and arms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Affective Disorders Psychological Stress Inflammation Oxidative Stress Anxiety Disorders Mood Disorders Emotions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Waiting list, intervention after EOS

control group / waiting list one week stress-coping intervention planned after end of study (EOS) without one week stress-coping intervention AND without an additional two days follow-up care

Group Type NO_INTERVENTION

No interventions assigned to this group

Stress-coping week without follow-up

active comparator with one week stress-coping intervention BUT without an additional two days follow-up weekend

Group Type ACTIVE_COMPARATOR

stress-coping week

Intervention Type BEHAVIORAL

The multidisciplinary team will offer Mindfulness-Based Stress Reduction (MBSR), group psychotherapy (resilience, Cognitive Behavioral Analysis System of Psychotherapy CBASP, psychodynamic therapy), relaxation training, nutrition course, stress-coping and physical training in a group setting.

Stress-coping week with follow-up

active comparator with one week stress-coping intervention AND with an additional two days follow-up weekend

Group Type ACTIVE_COMPARATOR

stress-coping week

Intervention Type BEHAVIORAL

The multidisciplinary team will offer Mindfulness-Based Stress Reduction (MBSR), group psychotherapy (resilience, Cognitive Behavioral Analysis System of Psychotherapy CBASP, psychodynamic therapy), relaxation training, nutrition course, stress-coping and physical training in a group setting.

additional two days follow-up weekend

Intervention Type BEHAVIORAL

A two-days follow-up which recapitulates previous treatment elements.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

stress-coping week

The multidisciplinary team will offer Mindfulness-Based Stress Reduction (MBSR), group psychotherapy (resilience, Cognitive Behavioral Analysis System of Psychotherapy CBASP, psychodynamic therapy), relaxation training, nutrition course, stress-coping and physical training in a group setting.

Intervention Type BEHAVIORAL

additional two days follow-up weekend

A two-days follow-up which recapitulates previous treatment elements.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Affective or anxiety disorder DSM-IV diagnosis (structured interview, M.I.N.I. International Neuropsychiatric Interview )
* Minimum 3-weeks previous therapeutic treatment as outpatient at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria
* Clinical Global Impression - Severity (CGI-S) score \> 2 points
* Minimum improvement of 1 CGI-S points as outpatient
* Written informed consent

Exclusion Criteria

* More than 60 days away sick per year in the last year before intervention
* Therapy adherence as outpatient at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria
* Work Ability Index (WAI) score \< 25 points
* Major neurological or cognitive deficits
* Current psychotic symptoms
* Current or previous DSM-IV diagnosis of substance dependence, except for nicotine or current substance abuse
* Failures to comply with the study protocol or to follow the instructions of the study team
* Currently requested application for retirement
* Middle to high suicidal tendency in the M.I.N.I.-examination

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No